ID: MRFR/Pharma/1737-HCR | February 2021 | Region: Global | 85 pages
Market Synopsis of Global Ulcerative Colitis Market:
Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum part of human body. Inflammation and ulcers are formed in the innermost lining of the colon and rectum, resulting in the production of pus and mucous in these linings. Abdominal cramps, diarrhea, and rectal bleeding are among the common symptoms observed in individuals suffering with the disease.
FIGURE 1 GLOBAL ULCERATIVE COLITIS MARKET BY TYPES
Global Ulcerative Colitis Market is segmented on the basis of types and medication. Based on procedures, the market is segmented into ulcerative proctitis, proctosigmoiditis, left-sided colitis, pancolitis or universal colitis, and fulminant colitis. Further on the basis of medication the market is classified into 5-aminosalicylates, steroids, purine analogs, immunomodulators, and biologics
Key players of Global Ulcerative colitis Market:
Key players profiled in the ulcerative colitis market report are Allergan, Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, and Bayer AG, UCB S.A., Perrigo Company plc, Pfizer Inc., Johnson & Johnson Services, Inc., Ferring B.V.
The report for Global Ulcerative Colitis Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
Frequently Asked Questions (FAQ) :
ulcerative colitis market is projected grow at approximately 7% CAGR during the assessment period (2016-2022).
The ulcerative proctitis segment by types and the Biologics segment on the basis of medication hold larger shares in the global ulcerative colitis market.
Increasing prevalence of ulcerative colitis, healthier investments in R&D programs, and rising per capita healthcare expenditure of nations are major drivers of the global ulcerative colitis market.
North America holds the largest share in the global ulcerative colitis market, followed by Europe and the Asia Pacific, respectively.
AbbVie Inc., Allergan, Inc., Takeda Pharmaceutical Company Limited, UCB S.A., Bayer AG, Perrigo Company plc, Johnson & Johnson Services, Inc., Pfizer Inc., Ferring B.V., Merck & Co. and Janssen Biotech, are some of the major players operating in the ulcerative colitis market.
Table of Contents
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5 GLOBAL ULCERATIVE COLITIS MARKET, BY TYPE
5.1 ULCERATIVE PROCTITIS
5.3 LEFT-SIDED COLITIS
5.4 PANCOLITIS OR UNIVERSAL COLITIS
5.5 FULMINANT COLITIS
6. GLOBAL ULCERATIVE COLITIS MARKET, BY MEDICATION
6.3 PURINE ANALOG
7. GLOBAL ULCERATIVE COLITIS MARKET, BY REGION
7.1 NORTH AMERICA
7.4 MIDDLE EAST & AFRICA
8. COMPETITIVE LANDSCAPE
8.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
8..1.1 STRATEGIC PARTNERSHIP
8..1.2 MERGER & ACQUISITION
9 COMPANY PROFILE
9.1 ABBVIE INC.
9.1.2 PRODUCT OVERVIEW
9.1.4 KEY DEVELOPMENTS
9.2 BAYER AG.
9.2.2 PRODUCT OVERVIEW
9.2.4 KEY DEVELOPMENTS
9.3 JOHNSON & JOHNSON SERVICES, INC.,
9.3.2 PRODUCT OVERVIEW
9.3.5 KEY DEVELOPMENT
9.4 TAKEDA PHARMACEUTICAL COMPANY LIMITED
9.4.2 PRODUCT OVERVIEW
9.4.4 KEY DEVELOPMENTS
9.5 PFIZER INC.
9.5.2 PRODUCT OVERVIEW
9.5.4 KEY DEVELOPMENTS
List of Tables
TABLE 1 GLOBAL ULCERATIVE COLITIS MARKET, BY TYPE, 2013-2022 (USD MILLION)
TABLE 2 GLOBAL ULCERATIVE COLITIS MARKET, BY MEDICATION, 2013-2022 (USD MILLION)
TABLE 3 GLOBAL ULCERATIVE COLITIS MARKET BY REGION 2013-2022 (USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 GLOBAL ULCERATIVE COLITIS MARKET, BY TYPE
FIGURE 4 GLOBAL ULCERATIVE COLITIS MARKET, BY MEDICATION
FIGURE 5 GLOBAL ULCERATIVE COLITIS MARKET, BY REGION
FIGURE 6 GLOBAL ULCERATIVE COLITIS MARKET: COMPANY SHARE ANALYSIS, 2015 (%)